Apimeds Pharmaceuticals US (APUS) Intangibles (2025 - 2026)
Apimeds Pharmaceuticals US (APUS) recorded Intangibles of $116.74 million in Q2 2026.
Powered by 
Analysis
Apimeds Pharmaceuticals US (APUS) Intangibles (2025 - 2026) Analysis & Trends
At the end of FY2025, Apimeds Pharmaceuticals US reported Intangibles of $149.89 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Apimeds Pharmaceuticals US | 5.65 Mn | -13.98 Mn | - | 116.74 Mn |
API Access
Apimeds Pharmaceuticals US Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=APUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "APUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=APUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();